Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
Clinical trial NCT04959175 · RECRUITING
Trial details
- NCT number
- NCT04959175
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-23
- Primary completion
- 2027-04-27
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.